A healthcare professional prepares a vaccine syringe in an African clinic, highlighting medical efforts in the region.
Guinea-Bissau has suspended a controversial US-funded hepatitis B vaccine study, igniting a debate over ethics, power, and national sovereignty in global health research. The decision was taken by Guinea-Bissau’s recently appointed health minister, who cited inadequate ethical review. The trial, led by Danish researchers, planned to withhold hepatitis B vaccines from some newborns, a design African health experts called unacceptable, especially in a country with high hepatitis B rates. The clash highlights a broader tension about who sets the agenda for medical research in lower-income countries, with local leaders demanding studies that align with their communities’ actual needs and ethical standards. The future of the trial now depends on a sovereign review, putting global research partnerships under new scrutiny.
The Guardian